Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. - Wikidata - awgldk - TriplyDB

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

http://www.wikidata.org/entity/Q44551404

about

Abuse of amphetamines and structural abnormalities in the brain Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD Potential adverse effects of amphetamine treatment on brain and behavior: a review Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.Lisdexamfetamine dimesylate: the first prodrug stimulant.Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.Priorities and standards in pharmacogenetic research.The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.Pharmacologic mechanisms of crystal meth.Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder.Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release).A review of psychostimulant-induced neuroadaptation in developing animals.Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study.Long-acting stimulants: development and dosing.The laboratory school protocol: its origin, use, and new applications.A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.Effects of single dose mixed amphetamine salts--extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder

P2860

Q22241673-F43BF091-E814-4741-AB32-397138173202 Q22241803-F39DA03E-B1DE-4C83-A5C7-640A4FFF22D8 Q24657966-D2D8E785-19C6-420D-B774-D0D76B4FFB24 Q26750486-2638C973-4B7C-4F57-A32F-15B73B9706C1 Q26822392-FF2BBB54-877A-4519-9DD1-4608A6BB5ADF Q33870580-ECA37162-4C28-4E9D-A28A-DA0ADC742931 Q33881547-4713DC05-DECD-4DB0-A59E-D836D6AC8577 Q33894687-A1535EF2-8797-4973-BC65-DF351085F947 Q36161293-0CF19F75-82C4-4939-84CF-B8B44E379D23 Q36180606-01CA4F4C-3281-4896-B8EB-1D9089646DE5 Q36699910-51D6C955-3C92-4592-A95F-70D5E8E1078C Q36700620-298112D9-4E1A-45BB-A17B-16EFF901C7C5 Q36787283-CE404744-DE20-4900-AE71-72E8180D031F Q36916927-E89E7E3B-0A54-4238-AE4D-59F068AAB1FD Q37879918-2A6D1F2E-1D90-4660-81B0-83C0DBA47225 Q37960505-706A3356-0A21-4094-AC8E-41D1B0E7FDBC Q42739125-DAC76E5A-9D08-418E-B598-CE2E62556D83 Q42761512-CEA28E4E-701A-40C7-9410-1AE7963FB090 Q45982454-57818281-496C-4C4C-AF47-219130B432E8 Q53045341-8B800406-2765-4C8F-8045-C089B0B90770 Q53379362-34BAF1A6-A917-4897-9872-7514AD717D26 Q57400056-3C7EE809-E1E6-4870-AA2D-07B59298998C

P2860

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

http://www.wikidata.org/entity/Q44551404

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@en

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@nl

type

label

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@en

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@nl

prefLabel

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@en

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@nl

P1433

Q44551404-5F375FB8-A745-4332-829E-8F097E76AE08

P1476

Q44551404-1187920E-05EE-4B9E-8B8A-969299AE0685

P2093

Q44551404-40776D33-E87F-449A-A08D-65C21171A41D

Q44551404-6E18CA02-3F7D-4F36-AF29-800179AE4666

Q44551404-74A94BD0-BF0E-41F8-B251-1466885311B3

Q44551404-74CFF163-C7C2-44DC-841F-E5D2278FF0F2

Q44551404-91AC4F87-3C1D-4C2D-AD7D-115904FEBFD7

Q44551404-9ADEE39F-640A-4514-AEA7-0A766F5536CF

Q44551404-B3DFDEB7-79A9-423A-B10E-7F738455D7E6

Q44551404-B55EAC33-04E8-49BC-99EC-008B315F1757

Q44551404-DDF5761A-6E64-4367-BD49-D7E1041F6698

Q44551404-DF580564-D05C-4946-92D4-0463E016FD18

P304

Q44551404-2229E08B-BE89-4786-9C26-51A5BD9C5D8C

P31

Q44551404-4B17856E-C25B-417E-8130-9AF8A2479840

P356

Q44551404-15FC207D-3F16-44FA-9B84-08A13BA6EC3B

P433

Q44551404-3ADE09AE-B641-4BB3-A27B-B0DDDCC1A278

P478

Q44551404-59BD6F03-77AB-45D7-8948-DC7BDB730141

P577

Q44551404-30634DE4-584F-4674-B2A4-FE7B14957905

P698

Q44551404-351B0798-2E04-4594-AB7F-2D8188015717

P356

01.CHI.0000046850.56865.CB

P1433

Journal of the American Academy of Child and Adolescent Psychiatry

P1476

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

@en

P2093

James J McGough

http://www.w3.org/2001/XMLSchema#string

James M Swanson

http://www.w3.org/2001/XMLSchema#string

James T McCracken

http://www.w3.org/2001/XMLSchema#string

Jeffrey Gornbein

http://www.w3.org/2001/XMLSchema#string

Joseph Biederman

http://www.w3.org/2001/XMLSchema#string

Kelly Posner

http://www.w3.org/2001/XMLSchema#string

Laurence L Greenhill

http://www.w3.org/2001/XMLSchema#string

Sharon Wigal

http://www.w3.org/2001/XMLSchema#string

Simon Tulloch

http://www.w3.org/2001/XMLSchema#string

Thomas J Spencer

http://www.w3.org/2001/XMLSchema#string

P304

684-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.CHI.0000046850.56865.CB

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12921476

http://www.w3.org/2001/XMLSchema#string